Abstract
Adults with inflammatory bowel disease (IBD) have an increased risk for vascular events. This study aims to evaluate arterial parameters in paediatric IBD. Carotid intima-media thickness (CIMT) was measured by ultrasound, and Arteriograph was used to assess aortic pulse wave velocity (PWVao), brachial and aortic augmentation indexes (AixBrach, AixAo), central systolic blood pressure (SBPao), and heart rate (HR). A total of 161 children were included; 55 (34%) children with newly diagnosed IBD (median age 14.35 (11.88–16.31) years, 53% males), 53(33%) in remission (median age 15.62 (13.46–16.70) years, 66% males), and 53 (33%) controls (median age 14.09 (11.18–14.09) years, 55% males) were recruited into a case–control study. Compared to controls, patients with active disease and those in clinical remission had significantly lower AixBrach and AixAo (P < 0.001, P = 0.009; P < 0.001, P = 0.003). PWVao and CIMT were still normal. HR was higher in both IBD groups than in controls (P < 0.001; P = 0.006). HR positively correlated with disease duration (P = 0.001). In the ordinary least squares regression models, anti-tumour necrosis factor (TNF) α treatment predicted lower peripheral and central systolic blood pressures, in contrast to aminosalicylates and methotrexate. Aminosalicylate treatment predicted increased HR.
Conclusion: Children with IBD have an increased heart rate, a lower augmentation index and, therefore, an altered pulse waveform. In paediatric IBD, arterial stiffness and CIMT are still normal, indicating the potential for adequate IBD treatment to preserve arterial health.
What is Known: |
• Adult patients with inflammatory bowel disease (IBD) have increased carotid intima-media thickness and arterial stiffness, which positively correlates with cardiovascular risk and predicts mortality. Adequate treatment, especially anti-tumour necrosis factor (TNF) α medications, lower these risks. |
• Children with IBD have impaired endothelial function and reduced heart rate (HR) variability. |
What is New: |
• Children with IBD have impaired endothelial function and reduced heart rate (HR) variability. |
• Anti-TNFα treatment in children and adolescents with IBD lowers systolic pressure, whereas methotrexate and aminosalicylates have the opposite effect. Amiynosalyiciylate treatment also increases HR. |
Similar content being viewed by others
Data availability
Data is available on request from the authors.
Abbreviations
- Aix:
-
Augmentation index
- AixAo:
-
Aortic augmentation index
- AixBrach:
-
Brachial augmentation index
- BMI:
-
Body mass index
- CD:
-
Crohn’s disease
- cfPWV:
-
Carotid-femoral pulse wave velocity
- CIMT:
-
Carotid intima-media thickness
- CRP:
-
C-reactive protein
- DBP:
-
Diastolic blood pressure
- EEN:
-
Exclusive enteral nutrition
- ESR:
-
Erythrocyte sedimentation rate
- HR:
-
Heart rate
- IBD:
-
Inflammatory bowel disease
- IBDU:
-
Inflammatory bowel disease unclassified
- IQR:
-
Interquartile range
- OLS:
-
Ordinary least squares
- PCDAI:
-
Pediatric Crohn’s Disease Activity Index
- PUCAI:
-
Pediatric Ulcerative Colitis Activity Index
- PWV:
-
Pulse wave velocity
- PWVao:
-
Aortic pulse wave velocity measured by Arteriograph
- P1:
-
Forward wave
- P2:
-
Reflected wave
- SBP:
-
Systolic blood pressure
- SBPao:
-
Central systolic blood pressure
- UC:
-
Ulcerative colitis
- TNF:
-
Tumour necrosis factor
References
Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327. https://doi.org/10.1016/j.jacc.2009.10.061
Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605. https://doi.org/10.1093/eurheartj/ehl254
Lorenz MW, Polak JF, Kavousi M et al (2012) Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 379:2053–2062. https://doi.org/10.1016/S0140-6736(12)60441-3
Arida A, Protogerou AD, Kitas GD, Sfikakis PP (2018) Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases. Int J Mol Sci 19(7):1890. https://doi.org/10.3390/ijms19071890
Ghione S, Sarter H, Fumery M et al (2018) Dramatic increase in incidence of ulcerative colitis and Crohn’s disease (1988–2011): a population-based study of French adolescents. Am J Gastroenterol 113(2):265–272. https://doi.org/10.1038/ajg.2017.228
Bigeh A, Sanchez A, Maestas C, Gulati M (2019) Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease? Trends Cardiovasc Med 30(8):463–469. https://doi.org/10.1016/j.tcm.2019.10.001
Choi YJ, Lee DH, Shin DW et al (2019) Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther 50:769–779. https://doi.org/10.1111/apt.15446
Üstün Y, Kilincalp S, Çoban Ş et al (2016) Evaluation of early atherosclerosis markers in patients with inflammatory bowel disease. Med Sci Monit 22:3943–3950. https://doi.org/10.12659/msm.898160
Wu G-C, Leng R-X, Lu Q et al (2017) Subclinical atherosclerosis in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Angiology 68:447–546. https://doi.org/10.1177/0003319716652031
Cappello M, Licata A, Calvaruso V et al (2017) Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease. Eur J Intern Med 37:83–89. https://doi.org/10.1016/j.ejim.2016.10.004
Kothari HG, Gupta SJ, Gaikwad NR (2019) Utility of carotid intima-media thickness as an auxiliary vascular parameter of structural alteration in ulcerative colitis. Inflamm Intest Dis 4:27–34. https://doi.org/10.1159/000499199
Bruzzese V, Palermo G, Ridola L et al (2017) Preclinical atherosclerosis in patients with inflammatory bowel diseases: a case-control study. Ann Transl Med 5:158. https://doi.org/10.21037/atm.2017.03.68
Dorfman L, Ghersin I, Khateeb N et al (2020) Cardiovascular risk factors are not present in adolescents with inflammatory bowel disease. Acta Paediatr 109:2380–2387. https://doi.org/10.1111/apa.15237
Zanoli L, Rastelli S, Inserra G, Castellino P (2015) Arterial structure and function in inflammatory bowel disease. World J Gastroenterol 21:11304–21131. https://doi.org/10.3748/wjg.v21.i40.11304
IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (2005) Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 41(1):1–7. https://doi.org/10.1097/01.mpg.0000163736.30261.82
Hyams J, Markowitz J, Otley A et al (2005) Evaluation of the Pediatric Crohn Disease Activity Index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 41:416–421. https://doi.org/10.1097/01.mpg.0000183350.46795.42
Turner D, Otley AR, Mack D et al (2007) Development, validation, and evaluation of a Pediatric Ulcerative Colitis Activity Index: a prospective multicenter study. Gastroenterology 133:423–432. https://doi.org/10.1053/j.gastro.2007.05.029
Horváth IG, Németh Á, Lenkey Z et al (2010) Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28:2068. https://doi.org/10.1097/HJH.0b013e32833c8a1a
Davies JM, Bailey MA, Griffin KJ, Scott DJA (2012) Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. Vascular 20:342–349. https://doi.org/10.1258/vasc.2011.ra0054
Rossen NB, Laugesen E, Peters CD et al (2014) Invasive validation of Arteriograph estimates of central blood pressure in patients with type 2 diabetes. Am J Hypertens 27:674–679. https://doi.org/10.1093/ajh/hpt162
Stein JH, Johnson HM (2010) Carotid intima-media thickness, plaques, and cardiovascular disease risk: implications for preventive cardiology guidelines. J Am Coll Cardiol 55:1608–1610. https://doi.org/10.1016/j.jacc.2009.11.073
Levine A, Griffiths A, Markowitz J et al (2011) Pediatric modification of the Montreal Classification for inflammatory bowel disease: The Paris Classification. Inflamm Bowel Dis 6:1314–1321. https://doi.org/10.1002/ibd.21493
Zanoli L, Rastelli S, Granata A et al (2016) Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis. J Hypertens 34:822–829. https://doi.org/10.1097/HJH.0000000000000867
Fan F, Galvin A, Fang L et al (2014) Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease. J Inflamm 11:29. https://doi.org/10.1186/s12950-014-0029-0
Aloi M, Tromba L, Di Nardo G et al (2012) Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr 161:589–594. https://doi.org/10.1016/j.tcm.2019.10.001
Andreozzi M, Giugliano FP, Strisciuglio T et al (2019) The role of inflammation in the endothelial dysfunction in a cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 69:330–335. https://doi.org/10.1016/j.jpeds.2012.03.043
Petr J, Michal H, Jan S et al (2014) Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn’s disease is significantly lower than healthy controls. Acta Paediatr 103:e55–e60. https://doi.org/10.1111/apa.12467
Lurz E, Aeschbacher E, Carman N et al (2017) Pulse wave velocity measurement as a marker of arterial stiffness in pediatric inflammatory bowel disease: a pilot study. Eur J Pediatr 176:983–987. https://doi.org/10.1007/s00431-017-2927-7
Protogerou A, Safar M (2007) Dissociation between central augmentation index and carotid-femoral pulse-wave velocity: When and why? Am J Hypertens 20:648–649. https://doi.org/10.1016/j.amjhyper.2007.02.008
Weber T, O’Rourke MF, Ammer M et al (2008) Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 21:1194–1202. https://doi.org/10.1038/ajh.2008.277
Tartière J-M, Logeart D, Safar ME, Cohen-Solal A (2006) Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure. J Hum Hypertens 20:213–219. https://doi.org/10.1038/sj.jhh.1001965
van de Velde L, Eeftinck Schattenkerk DW, Venema PAHT et al (2018) Myocardial preload alters central pressure augmentation through changes in the forward wave. J Hypertens 36:544–551. https://doi.org/10.1097/HJH.0000000000001583
Sakurai M, Yamakado T, Kurachi H et al (2007) The relationship between aortic augmentation index and pulse wave velocity: an invasive study. J Hypertens 25:391–397. https://doi.org/10.1097/HJH.0b013e3280115b7c
Georgianos PI, Sarafidis PA, Malindretos P et al (2011) Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol 34:407–414. https://doi.org/10.1159/000331700
Nichols WW, Denardo SJ, Wilkinson IB et al (2008) Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens 10:295–303. https://doi.org/10.1111/j.1751-7176.2008.04746.x
Wilkinson IB, Mohammad NH, Tyrrell S et al (2002) Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 15:24–30. https://doi.org/10.1016/s0895-7061(01)02252-x
Kuilder JS, Idris NS, Grobbee DE et al (2017) Association between human immunodeficiency virus infection and arterial stiffness in children. Eur J Prev Cardiol 24:480–488. https://doi.org/10.1177/2047487316680694
Öztürk GK, Eşki̇ A, Çeli̇k FÇ et al (2020) Prospective evaluation of vascular changes in acute respiratory infections in children with cystic fibrosis. Turk J Med Sci 50:1007–1014. https://doi.org/10.3906/sag-2002-61
Mogilevski T, Burgell R, Aziz Q, Gibson PR (2019) Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD. Aliment Pharmacol Ther 50:720–737. https://doi.org/10.1111/apt.15433
Jelenova D, Ociskova M, Prasko J et al (2015) Heart rate variability in children with inflammatory bowel diseases. Neuro Endocrinol Lett 36:72–79
Yerushalmy-Feler A, Cohen S, Lubetzky R et al (2022) Heart rate variability as a predictor of disease exacerbation in pediatric inflammatory bowel disease. J Psychosom Res 158:110911. https://doi.org/10.1016/j.jpsychores.2022.110911
Aloi M, Tromba L, Rizzo V et al (2015) Aortic intima-media thickness as an early marker of atherosclerosis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 61:41. https://doi.org/10.1097/MPG.0000000000000771
Ilisson J, Zagura M, Zilmer K et al (2015) Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis. Arthritis Res Ther 17(1):18. https://doi.org/10.1186/s13075-015-0699-x
Ozturk K, Guler AK, Cakir M et al (2015) Pulse wave velocity, intima-media thickness, and flow-mediated dilatation in patients with normotensive normoglycemic inflammatory bowel disease. Inflamm Bowel Dis 21(6):1314–1320. https://doi.org/10.1097/MIB.0000000000000355
Kayahan H, Sari I, Cullu N et al (2012) Evaluation of early atherosclerosis in patients with inflammatory bowel disease. Dig Dis Sci 57:2137–2143. https://doi.org/10.1007/s10620-012-2148-x
Kirchgesner J, Andersen NN, Carrat F et al (2020) Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut 69:852–858. https://doi.org/10.1136/gutjnl-2019-318932
Schinzari F, Armuzzi A, De Pascalis B et al (2008) Tumor necrosis factor-α antagonism improves endothelial dysfunction in patients with Crohn’s disease. Clin Pharmacol Ther 83:70–76. https://doi.org/10.1038/sj.clpt.6100229
Altorjay I, Veréb Z, Serfőző Z et al (2011) Anti-TNF-α antibody (Infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cells. Int J Immunopathol Pharmacol 24:323–335. https://doi.org/10.1177/039463201102400206
Zanoli L, Rastelli S, Inserra G et al (2014) Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs. Atherosclerosis 234(2):346–351. https://doi.org/10.1016/j.atherosclerosis.2014.03.023
Zanoli L, Ozturk K, Cappello M et al (2019) Inflammation and aortic pulse wave velocity: a multicenter longitudinal study in patients with inflammatory bowel disease. J Am Heart Assoc. https://doi.org/10.1161/JAHA.118.010942
Mitchell JA, Warner TD (2006) COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov 5:75–86. https://doi.org/10.1038/nrd1929
Bălănescu A-R, Bojincă VC, Bojincă M et al (2019) Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases. Exp Ther Med 17:1024–1029. https://doi.org/10.3892/etm.2018.6992
Sundström J, Sullivan L, D’Agostino RB et al (2003) Plasma homocysteine, hypertension incidence, and blood pressure tracking: the Framingham Heart Study. Hypertension 42:1100–1105. https://doi.org/10.1161/01.HYP.0000101690.58391.13
Acknowledgements
Special thanks to the nursing staff of the Department of Paediatrics, Children’s Hospital Zagreb, especially Višnjica Kerman, Bernarda Kovačević, Nataša Tomašić, and Katarina Kral for the kind help in collecting patients and the testing itself.
Funding
This work was supported by Croatian Science Foundation (Chronic bowel diseases in children: looking beyond the gut; grant number-IP-2019–04-3028).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design, material preparation, and data collection. V Tokić Pivac conducted data analysis. V Tokić Pivac wrote the first draft, and all authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Ethical Committees at Children’s Hospital Zagreb and the University of Zagreb School of Medicine approved the study design.
Informed consent
At least one parent or guardian and children older than eight had signed the informed consent.
Competing interests
Authors V Tokić Pivac, V Herceg-Čavrak, Z Mišak, and O Jadrešin have no competing interests to declare that are relevant to the content of this article. I Hojsak received payment for lectures: BioGaia, Nutricia, Biocodex, AbelaPharm, Nestle, Abbott, Sandoz, Oktal pharma, and Takeda. S Kolaček received lecture fees from Abbott, AbbVie, Abela pharm, GM Pharma, Nestle, Nestle Nutrition Institute, Nutricia, Oktal Pharma, and Takeda.
Additional information
Communicated by Peter de Winter.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pivac, V.T., Herceg-Čavrak, V., Hojsak, I. et al. Children with inflammatory bowel disease already have an altered arterial pulse wave. Eur J Pediatr 182, 1771–1779 (2023). https://doi.org/10.1007/s00431-023-04858-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-04858-9